[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369676-105":59,"doc-detail-369676-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","cortactin-facilitates-malignant-transformation-of-dysplastic-cells-in-gastric-cancer-development","Cortactin Facilitates Malignant Transformation of Dysplastic Cells in Gastric Cancer Development","","Cortactin is shown to play a novel, functional role in driving the malignant transformation of dysplastic cells during gastric cancer development. The study addresses the limited understanding of how precancerous dysplasia progresses to malignancy by testing cortactin’s contribution to actin stabilization and regulatory control of exosome secretion. Using a CRISPR/Cas9 cortactin knockout dysplasia organoid model, results link cortactin loss to impaired malignant conversion in vitro and in vivo, accompanied by reduced exosome secretion and altered tumor microenvironment recruitment.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cortactin-facilitates-malignant-transformation-of-dysplastic-cells-in-gastric-cancer-development/369676/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cortactin-facilitates-malignant-transformation-of-dysplastic-cells-in-gastric-cancer-development/369676.png","ImageObject",300,407,{"name":92,"@type":93},"Terk","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-19","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is cortactin’s proposed role in this study?","Question",{"text":112,"@type":113},"Cortactin is proposed to facilitate malignant transformation of dysplastic cells by supporting actin stabilization and regulating exosome secretion.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the cortactin function tested experimentally?",{"text":117,"@type":113},"Researchers created a CRISPR/Cas9 cortactin knockout (KO) dysplasia organoid model and evaluated malignant behavior in vitro and in vivo.",{"name":119,"@type":110,"acceptedAnswer":120},"What major outcomes were observed when cortactin was knocked out?",{"text":121,"@type":113},"Dysplastic identity was retained, but KO organoids showed reduced cellular organization and multicellular protrusions, and KO cells failed to form adenocarcinoma and solid tumors in nude mice.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},369676,1790326228,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099525198933,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","ORIGINAL RESEARCH   \nCortactin Facilitates Malignant Transformation of Dysplastic Cells in Gastric Cancer Development  \nAlexis A. Guenther, 1 ,2 ,* Suyeon Ahn, 1 ,3 ,* Jimin Min, 1 ,3 ,9 ,* Changqing Zhang, 1 ,3  \nHyuk-Joon Lee,4 ,5 Han-Kwang Yang,4 ,5 Bong Hwan Sung,2 ,6 ,7 Alissa M. Weaver,2 ,6 ,7 ,8 and Eunyoung Choi 1 ,2 ,3  \n1Epithelial Biology Center, Vanderbilt University Medical Center, Nashville, Tennessee; 2Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, Tennessee; 3Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee; 4Department of Surgery, Seoul National University College of Medicine, Seoul, Korea; 5Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; 6The Vanderbilt Center for Extracellular Vesicle Research, Vanderbilt University School of Medicine, Nashville, Tennessee; 7Program in Cancer Biology, Vanderbilt University School of Medicine, Nashville, Tennessee; 8Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee; and 9Current afﬁliation: Department of Translational Molecular Pathology, Sheikh Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas  \nSUMMARY  \nThis work reveals a novel role of cortactin in the malignant transformation of dysplastic cells, thereby contributing to the understanding of undiscovered cellular mechanisms in early gastric cancer biology.  \nBACKGROUND & AIMS: Epithelial cancer onset occurs through sequential stages of cell lineage conversion and functional dysregulation. Dysplasia is a precancerous lesion deﬁned as a direct precursor to cancer and is histologically deﬁned as a transition stage between pre-cancer and cancer, but molecular and biological mechanisms controlling its transformation to malignancy are underdetermined. Here, we discover the crucial role of the actin stabilization and exosome secretion-regulatory protein cortactin in dysplastic cell transformation to adenocarcinoma.  \nMETHODS: We engineered a CRISPR/Cas9-based cortactin knock-out (KO) dysplasia organoid model established from dysplastic tissue and examined malignant roles of cortactin during gastric cancer development in vitro and in vivo.  \nRESULTS: Although dysplastic cell identity remained unchanged, the cortactin KO organoids exhibited a decrease in cellular organization and multicellular protrusions, which are considered aggressive features when observed in vitro. When injected into the ﬂank of nude mice, cortactin KO cells failed malignant transformation into adenocarcinoma and solid tumor formation with reduced recruitment of ﬁbroblasts and macrophages. In addition, cortactin KO cells showed diminished exosome secretion levels, and adenocarcinoma development was impaired when exosome secretion was inhibited in cortactin wild-type dysplastic cells.  \nCONCLUSIONS: These data suggest that cortactin is a functional element of membrane dynamics, malignant changes, and exosome secretion in dysplastic cells, and solid gastric tumor formation associated with alteration of the tumor microenvironment. (Cell Mol Gastroenterol Hepatol 2025;19:101490; [https://doi.org/10.1016/j.jcmgh.2025.101490](https://doi.org/10.1016/j.jcmgh.2025.101490))  \nKeywords: Cortactin; Dysplasia; Extracellular Vesicles; Gastric Cancer; Metaplasia; Organoid; Tumor Formation.  \nUnderstanding the biology of pre-cancer has been  \nidentiﬁed as one of the top challenges in early cancer detection research. Gastric cancer is the ﬁfth leading cause of cancer-related deaths worldwide1 and arises through a series of carcinogenic stages including metaplasia and dysplasia.2 Dysplasia has been described as the last stage in epithelial gastric carcinogenesis, which occurs before invasive carcinomas develop and is often observed in metachronous cancers in patients.3,4 Recent investigations by our group suggest that a stem cell ","cbCaiagycFEiT73S","https://ap.wps.com/l/cbCaiagycFEiT73S","pdf",9623435,21,"English","# Summary\n# Background & Aims\n# Methods\n# Results\n# Conclusions\n# Keywords","[{\"question\":\"What is cortactin’s proposed role in this study?\",\"answer\":\"Cortactin is proposed to facilitate malignant transformation of dysplastic cells by supporting actin stabilization and regulating exosome secretion.\"},{\"question\":\"How was the cortactin function tested experimentally?\",\"answer\":\"Researchers created a CRISPR/Cas9 cortactin knockout (KO) dysplasia organoid model and evaluated malignant behavior in vitro and in vivo.\"},{\"question\":\"What major outcomes were observed when cortactin was knocked out?\",\"answer\":\"Dysplastic identity was retained, but KO organoids showed reduced cellular organization and multicellular protrusions, and KO cells failed to form adenocarcinoma and solid tumors in nude mice.\"}]","Cortactin Facilitates Malignant Transformation of Dysplastic Cells in Gastric Cancer Development | PDF",1790184066,53,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4f190cced04c14c7467e251cf5420195.webp",983,1296,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/90d01af3033973c1eb1a58dbec9d1502.webp",982,1294,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d51483001cc5f66e7e790152c1f3c0f5.webp",981,1293,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/76a4f27c26a5f9cee40522f02595fce9.webp",980,1292]